-+ 0.00%
-+ 0.00%
-+ 0.00%

ZENAS BIOPHARMA ANNOUNCES UPCOMING PRESENTATIONS OF ORELABRUTINIB DATA IN RELAPSING REMITTING MULTIPLE SCLEROSIS, CLINICAL TRIAL DESIGNS IN PROGRESSIVE MULTIPLE SCLEROSIS AND OTHER MULTIPLE SCLEROSIS PORTFOLIO DATA AT MSTORONTO2026

Reuters·10/07/2026 11:06:03